Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice
Min-Hyun Kim, … , Wen-Shu Wu, Liangyou Rui
Min-Hyun Kim, … , Wen-Shu Wu, Liangyou Rui
Published December 13, 2022
Citation Information: J Clin Invest. 2023;133(4):e156722. https://doi.org/10.1172/JCI156722.
View: Text | PDF
Research Article Cell biology Metabolism

LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice

  • Text
  • PDF
Abstract

Leptin exerts its biological actions by activating the long-form leptin receptor (LepRb). LepRb signaling impairment and leptin resistance are believed to cause obesity. The transcription factor Slug — also known as Snai2 — recruits epigenetic modifiers and regulates gene expression by an epigenetic mechanism; however, its epigenetic action has not been explored in leptin resistance. Here, we uncover a proobesity function of neuronal Slug. Hypothalamic Slug was upregulated in obese mice. LepRb+ cell–specific Slug-knockout (SlugΔLepRb) mice were resistant to diet-induced obesity, type 2 diabetes, and liver steatosis and experienced decreased food intake and increased fat thermogenesis. Leptin stimulated hypothalamic Stat3 phosphorylation and weight loss to a markedly higher level in SlugΔLepRb than in Slugfl/fl mice, even before their body weight divergence. Conversely, hypothalamic LepRb+ neuron–specific overexpression of Slug, mediated by AAV-hSyn-DIO-Slug transduction, induced leptin resistance, obesity, and metabolic disorders in mice on a chow diet. At the genomic level, Slug bound to and repressed the LepRb promoter, thereby inhibiting LepRb transcription. Consistently, Slug deficiency decreased methylation of LepRb promoter H3K27, a repressive epigenetic mark, and increased LepRb mRNA levels in the hypothalamus. Collectively, these results unravel what we believe to be a previously unrecognized hypothalamic neuronal Slug/epigenetic reprogramming/leptin resistance axis that promotes energy imbalance, obesity, and metabolic disease.

Authors

Min-Hyun Kim, Yuan Li, Qiantao Zheng, Lin Jiang, Martin G. Myers Jr., Wen-Shu Wu, Liangyou Rui

×

Figure 6

Hypothalamic LepRb neuron–specific overexpression of Slug induces obesity.

Options: View larger image (or click on image) Download as PowerPoint
Hypothalamic LepRb neuron–specific overexpression of Slug induces obesit...
(A) AAV-hSyn-DIO-Slug vectors were coinjected with either AAV-CAG-GFP or AAV-CAG-Cre vectors into the brains of C57BL/6J mice. Brain extracts were prepared 3 weeks later and immunoblotted with antibodies against Slug or α-tubulin. (B–H) AAV-hSyn-DIO-Slug or AAV-hSyn-DIO-mCherry vectors were bilaterally microinjected into the MBH of SlugΔLepRb (Slugfl/fl;LepRb-Cre+/+) males (8 weeks, on chow diet). Slugfl/fl males (lacking Cre) were injected with AAV-hSyn-DIO-Slug vectors (control). (B) Hypothalamic extracts were immunoblotted with antibodies against Slug or α-tubulin (12 weeks after AAV transduction). (C) Body weight. (D) Fat content at 12 weeks after AAV transduction (% body weight). (E) Tissue weight (12 weeks after AAV transduction). (F and G) GTT and ITT at 11 weeks after AAV transduction. (H) Liver TAG levels at 12 weeks after AAV transduction (normalized to liver weight). AAV-hSyn-DIO-Slug/ SlugΔLepRb, n = 8; AAV-hSyn-DIO-mCherry/SlugΔLepRb, n = 7; AAV-hSyn-DIO-Slug/Slugfl/fl, n = 4. (I and J) AAV-CAG-DIO-Slug or AAV-CAG-DIO-mCherry vectors were bilaterally microinjected into the MBH of SlugΔLepRb (Slugfl/fl;LepRb-Cre+/–) male mice at 9 weeks of age on chow diet (n = 5 mice per group). (I) Body weight. (J) GTT (2 g glucose/kg) and ITT (1 unit insulin/kg) at 8 weeks after AAV transduction. Data are presented as mean ± SEM. *P < 0.05, 1-way (D and E, F [right panel], G [right panel], and H) and 2-way (C, F [left panel], G [left panel], I, and J) ANOVA.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts